Updates from a single-center phase 2 study of PD-1 inhibitor combined with hypomethylating agent plus CAG regimen in patients with relapsed/refractory acute myeloid leukemia
一项单中心 II 期研究的最新进展,该研究评估了 PD-1 抑制剂联合去甲基化药物和 CAG 方案治疗复发/难治性急性髓系白血病患者的疗效。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1533467
Zhou, Hui-Sheng; Su, Yong-Feng; Wang, Jun; Hu, Ya-Lei; Wang, An; Xu, Lei; Wang, Yi-Zhi; Zheng, Xuan; Li, Yu-Qing; Min, Kai-Li; Gao, Chun-Ji; Liu, Dai-Hong; Gao, Xiao-Ning